Acute Porphyria Drugs

C01EA01 - Alprostadil

Not porphyrinogenic
NP

Rationale
Endogenous prostaglandin. No relevant CYP metabolism.
Chemical description
Prostaglandin E1.
Therapeutic characteristics
Alprostadil is used mainly in congenital heart disease and in erectile dysfunction.
Metabolism and pharmacokinetics
Metabolized in the lungs and excreted within 24 hours.
Preclinical data
None
Personal communication
None
Published experience
None
Similar drugs
Explore alternative drugs in similar therapeutic classes C01E / C01EA or go back.
References
Tradenames

Prostin VR Prostin VR Alprostadil · Vazostenon Alprestil · Alprostadil · Prostin Alprostadil · Pridax · Prostin · Vasaprostan Prostin Prostin VR Alprostadil · Prostivas Prostivas Prostavasin · Prostin VR Prostin Prostavasin · Prostin VR Prostin VR · Prostivas Alprostadil · Neupedix · Pridax · vasaprostan Neupedix · Vasostenoon Neupedix · Vasostenoon Alprostin
In cooperation with IpNet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙